Exogenous Indian hedgehog antagonist damages intervertebral discs homeostasis in adult mice
Background: Vismodegib, as an exogenous Indian hedgehog (Ihh) antagonist, has been approved by the Food and Drug Administration (FDA) for the clinical treatment of patients with basal cell carcinoma, and previous observations implicate the potential therapeutic of vismodegib in osteoarthritis treatm...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2022-09-01
|
| Col·lecció: | Journal of Orthopaedic Translation |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2214031X22000948 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
